This is the authors' abstract. We don't add key points for this paper.
Targeting patients with risk factors for chronic liver disease and stratifying them using TE can detect significant chronic liver disease above and beyond the approach based on liver enzyme elevation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chalmers et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: